Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

18 filings reported holding TRAW - Traws Pharma, Inc. - Common Stock, par value $.01 per share as of Q4 2024.
Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.14M shares of 7.01M outstanding shares and own 16.29% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (606K shares), PERCEPTIVE ADVISORS LLC (164K shares), Alyeska Investment Group, L.P. (117K shares), Ikarian Capital, LLC (98.5K shares), Vestal Point Capital, LP (75K shares), GEODE CAPITAL MANAGEMENT, LLC (20.8K shares), MORGAN STANLEY (15.7K shares), VANGUARD GROUP INC (13.1K shares), RENAISSANCE TECHNOLOGIES LLC (10.1K shares), and MILLENNIUM MANAGEMENT LLC (10K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.